SIFI > International Markets
International Markets
In the last years SIFI has undergone a virtuous growth of its business, evolving into an industrial group of companies, consolidating domestic leadership and expanding into international markets.

Internationalization for SIFI Group means exporting a brand that is synonymous with specialization and tradition in ophthalmology, quality and innovation, ethics and professionalism, scientific education and proximity to physicians and patients, high medical and technological contents and commitment to social responsibility.

SIFI group has acquired a strong presence in the Americas and in European countries, either through its own subsidiaries or through partnering commercial distributors.

Currently the global key markets include Mexico, Romania, Spain, UK, Russia and Turkey where SIFI already has a significant presence through exclusive distributors.

Direct subsidiaries are present in Mexico (Laboratorios SIFI de México S.A. de C.V.) and Romania (Oftafarma srl).

share & tag us with
#EyeCare #eyeinfo #health #innovation #business #eye #vision #leadership #pharma
#Development
“Vision is the art of seeing what is invisible to others.”
Jonathan Swift

 
 
General questions info@sifigroup.com   Products Quality QualityUnit@sifigroup.com       Pharmacovigilance pharmacovigilance@sifigroup.com   Vigilance...
 
Code of Ethics SIFI SpA S.I.F.I. - Società Industria Farmaceutica Italiana S.p.A. (Italian Pharmaceutical Industry Company) (Hereinafter also referred to as SIFI or the Company) has adopted...
 
International Markets In the last years SIFI has undergone a virtuous growth of its business, evolving into an industrial group of companies, consolidating domestic leadership and expanding...

On our Social Channels

From our News Center

MINI WELL READY, an innovative lens for the surgical correction of presbyopia has been registered and approved by the South Korean Ministry of Food & Drug Safety.   SIFI, Italian leader...
 

 

12 July

ATLANTA, July 12, 2017 (GLOBE NEWSWIRE) -- Alimera Sciences, Inc. (NASDAQ:ALIM) (Alimera), a leader in the commercialization, research, and development of prescription ophthalmic...
Follow Us!